Cited by 10Artificial Intelligence in HealthcareMobile Health and mHealth ApplicationsCancer survivorship and care

Towards an early warning system for monitoring of cancer patients using hybrid interactive machine learning

Open access
Trojan, Andreas, Laurenzi, Emanuele, Jüngling, Stephan, Roth, Sven, Kiessling, Michael, Atassi, Ziad, Kadvany, Yannick, Mannhart, Meinrad +3 more·2024·Frontiers in Digital Health

Abstract

Background: The use of smartphone apps in cancer patients undergoing systemic treatment can promote the early detection of symptoms and therapy side effects and may be supported by machine learning (ML) for timely adaptation of therapies and reduction of adverse events and unplanned admissions. Objective: We aimed to create an Early Warning System (EWS) to predict situations where supportive interventions become necessary to prevent unplanned visits. For this, dynamically collected standardized electronic patient reported outcome (ePRO) data were analyzed in context with the patient's individual journey. Information on well-being, vital parameters, medication, and free text were also considered for establishing a hybrid ML model. The goal was to integrate both the strengths of ML in sifting through large amounts of data and the long-standing experience of human experts. Given the limitations of highly imbalanced datasets (where only very few adverse events are present) and the limitations of humans in overseeing all possible cause of such events, we hypothesize that it should be possible to combine both in order to partially overcome these limitations. Methods: The prediction of unplanned visits was achieved by employing a white-box ML algorithm (i.e., rule learner), which learned rules from patient data (i.e., ePROs, vital parameters, free text) that were captured via a medical device smartphone app. Those rules indicated situations where patients experienced unplanned visits and, hence, were captured as alert triggers in the EWS. Each rule was evaluated based on a cost matrix, where false negatives (FNs) have higher costs than false positives (FPs, i.e., false alarms). Rules were then ranked according to the costs and priority was given to the least expensive ones. Finally, the rules with higher priority were reviewed by two oncological experts for plausibility check and for extending them with additional conditions. This hybrid approach comprised the application of a sensitive ML algorithm producing several potentially unreliable, but fully human-interpretable and -modifiable rules, which could then be adjusted by human experts. Results: From a cohort of 214 patients and more than 16’000 available data entries, the machine-learned rule set achieved a recall of 19% on the entire dataset and a precision of 5%. We compared this performance to a set of conditions that a human expert had defined to predict adverse events. This “human baseline” did not discover any of the adverse events recorded in our dataset, i.e., it came with a recall and precision of 0%. Despite more plentiful results were expected by our machine learning approach, the involved medical experts a) had understood and were able to make sense of the rules and b) felt capable to suggest modification to the rules, some of which could potentially increase their precision. Suggested modifications of rules included e.g., adding or tightening certain conditions to make them less sensitive or changing the rule consequences: sometimes further monitoring the situation, applying certain test (such as a CRP test) or applying some simple pain-relieving measures was deemed sufficient, making a costly consultation with the physician unnecessary. We can thus conclude that it is possible to apply machine learning as an inspirational tool that can help human experts to formulate rules for an EWS. While humans seem to lack the ability to define such rules without such support, they are capable of modifying the rules to increase their precision and generalizability. Conclusions: Learning rules from dynamic ePRO datasets may be used to assist human experts in establishing an early warning system for cancer patients in outpatient settings.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3389/fdgth.2024.1443987

Cites

32 of 32 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • AI-enabled models may detect early signals of treatment-related toxicity by integrating wearable-derived data with patient-reported symptoms and clinical variables.

    “AI-enabled models may detect early signals of treatment-related toxicity by integrating wearable-derived data with patient-reported symptoms and clinical variables.31”

    From Artificial Intelligence in Oncology: Practical Applications Across Clinical Care, Scholarship, and Translation. (2026) · cites this paper as [31]

    The Introduction and Methods describe an ML early-warning approach using patient-reported symptoms, vital parameters, and other clinical information. The Discussion and conclusions (page unavailable) describe wearable-derived data only as a possible future improvement; the study did not use it to detect early treatment-related toxicity and explicitly says it did not aim to discover serious adverse events as early as possible. (LLM, conf=0.88)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. [26]Domingos P. Metacost: a general method for making classifiers cost-sensitive. Proceedings of the Fifth ACM SIGKDD International Conference on Knowledge Discovery and Data Mining (1999). p. 155– 64. 10.1145/312129.312220 · DOI

Cited by

Sorted by citations

Authors
Trojan, A., Laurenzi, E., Jüngling, S., Roth, S., Kiessling, M., Atassi, Z., Kadvany, Y., Mannhart, M., Jackisch, C., Kullak-Ublick, G., & Witschel, H. F.
Affiliations
  • University Hospital Zurich (CH)
  • FHNW University of Applied Sciences and Arts Northwestern Switzerland (CH)
  • Breast Center (CH)
  • Sana Klinikum Offenbach (DE)
Corresponding author
Trojan, Andreas
Venue
Frontiers in Digital Health
Published
2024-08-14
Volume
6
Pages
1443987-1443987
ISSN
2673-253X (ISSN-L)
OpenAlex
W4401592572
Cited by
10
References
32
Citations by year
2026: 6 · 2025: 4
FWCI
3.06
Type
journal article
Language
en
Open access
Locations
  • Frontiers in Digital Health (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
  • Zurich Open Repository and Archive (University of Zurich) (submittedVersion, cc-by)
  • Institutional Repository (IHS Vienna) (cc-by)
Topics
  • Health Sciences › Health Professions › Health Information Management › Artificial Intelligence in Healthcare
  • Health Sciences › Health Professions › General Health Professions › Mobile Health and mHealth Applications
  • Health Sciences › Medicine › Oncology › Cancer survivorship and care
Keywords
early warning systems, cancer patients, electronic patient-reported outcomes, unplanned hospital visits, adverse event prediction, hybrid machine learning, rule-based learning, mobile application, patient monitoring, class imbalance, human-in-the-loop, expert validation, treatment side effects, vital parameters, free-text data, clinical decision support, precision oncology

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review